[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Pharmashot Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1022473214457348096.png) @Pharmashot PharmaShots | Iluminate.Innovate.Inspire

PharmaShots | Iluminate.Innovate.Inspire posts on X about eli lilly, eli, breast cancer, novo the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1022473214457348096/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1022473214457348096/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXX +111%
- X Year XXXXXX +252%

### Mentions: X [#](/creator/twitter::1022473214457348096/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1022473214457348096/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XXX +94%
- X Year XXX +305%

### Followers: XXXXX [#](/creator/twitter::1022473214457348096/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1022473214457348096/c:line/m:followers.svg)

- X Week XXXXX +0.18%
- X Month XXXXX +0.44%
- X Months XXXXX +1.90%
- X Year XXXXX +0.53%

### CreatorRank: undefined [#](/creator/twitter::1022473214457348096/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1022473214457348096/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1022473214457348096/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXX% [countries](/list/countries)  XXX%

**Social topic influence**
[eli lilly](/topic/eli-lilly) #189, [eli](/topic/eli) 2.1%, [breast cancer](/topic/breast-cancer) #1540, [novo](/topic/novo) 0.7%, [$21b](/topic/$21b) 0.7%, [$4528t](/topic/$4528t) 0.7%, [$500m](/topic/$500m) 0.7%, [sanofi](/topic/sanofi) 0.7%, [canada](/topic/canada) 0.7%, [pi](/topic/pi) XXX%

**Top accounts mentioned or mentioned by**
[@amgen](/creator/undefined) [@italfarmacoes](/creator/undefined) [@vertexpharma](/creator/undefined) [@jazzpharma](/creator/undefined) [@regeneron](/creator/undefined) [@eisaisdgs](/creator/undefined) [@biogen](/creator/undefined) [@bioarcticab](/creator/undefined) [@ablbioinc](/creator/undefined) [@gsk](/creator/undefined) [@pfizer](/creator/undefined) [@genmab](/creator/undefined) [@merck](/creator/undefined) [@novartis](/creator/undefined) [@jnjnews](/creator/undefined) [@angelinipharma](/creator/undefined) [@sanofi](/creator/undefined) [@zailabglobal](/creator/undefined) [@sunpharmalive](/creator/undefined) [@novonordisk](/creator/undefined)

**Top assets mentioned**
[Eli Lilly and Company (LLY)](/topic/eli-lilly) [Sanofi (SNY)](/topic/sanofi)
### Top Social Posts [#](/creator/twitter::1022473214457348096/posts)
---
Top posts by engagements in the last XX hours

"Novo Nordisk Signs $2.1B Deal with Omeros Corporation to Advance Zaltenibart for Rare Blood & Kidney Disorders #novonordisk #omeros #zaltenibart #oms906 #piii #paroxysmalnocturnalhemoglobinuria #masp3inhibitor #kidneydisorders #licensingdeal #pharma"  
[X Link](https://x.com/Pharmashot/status/1978729218017034473) [@Pharmashot](/creator/x/Pharmashot) 2025-10-16T07:46Z 2278 followers, XX engagements


"ONO PHARMACEUTICAL CO. LTD. Reveals the P-II (ONO-4578-08) Trial Findings of ONO-4578 in Gastric or Gastroesophageal Junction Cancer #ono #pii #ono457808 #ono4578 #ep4antagonist #gastriccancer #gastroesophagealjunctioncancer #opdivo #clinicaltrial"  
[X Link](https://x.com/Pharmashot/status/1976616134733668856) [@Pharmashot](/creator/x/Pharmashot) 2025-10-10T11:49Z 2278 followers, XX engagements


"EVOQ Therapeutics Enters $500M Partnership with Sanofi to Advance NanoDisc Technology #evoq #sanofi #nanodiscplatform #licensingdeal #immunology #autoimmunedisorders #celiacdisease #type1diabetes #mogadantibodydisease #rheumatoidarthritis #lupus #pharma"  
[X Link](https://x.com/Pharmashot/status/1979072965368054177) [@Pharmashot](/creator/x/Pharmashot) 2025-10-17T06:32Z 2279 followers, XX engagements


"Eli Lilly and Company Reveals Topline P-III (monarchE) Trial Data of Verzenio (Abemaciclib) to Treat Early Breast Cancer #elililly #piii #monarche #verzenio #earlybreastcancer #toplinedata #clinicaltrial #ly2835219 #abemaciclib"  
[X Link](https://x.com/Pharmashot/status/1961016855264460806) [@Pharmashot](/creator/x/Pharmashot) 2025-08-28T10:43Z 2279 followers, XXX engagements


"Eli Lilly and Companys Kisunla (Donanemab) Receives Approval in the EU to Treat Early Symptomatic Alzheimer's Disease #a4250 #health #canada #odevixibat #bylvay #cholestatic #alagille #familial #medison #ipsen #piii #assert #approval #regulatory"  
[X Link](https://x.com/Pharmashot/status/1971475075254964236) [@Pharmashot](/creator/x/Pharmashot) 2025-09-26T07:21Z 2280 followers, XX engagements


"Eli Lilly and Companys Inluriyo (Imlunestrant) Gains the US FDAs Approval for ESR1-mutated Breast Cancer #elililly #inluriyo #imlunestrant #usfda #approval #breastcancer #esr1mutation #piii #ember3 #ember4 #ember #pi #abemaciclib #ly3484356"  
[X Link](https://x.com/Pharmashot/status/1971504713477853450) [@Pharmashot](/creator/x/Pharmashot) 2025-09-26T09:18Z 2279 followers, XXX engagements


"Eli Lilly and Company Reveals Topline Data from P-III (ACHIEVE-2 & 5) Trials of Orforglipron for Type X Diabetes #elililly #piii #achieve2 #achieve5 #orforglipron #type2diabetes #achieve4 #owl833 #ly3502970 #obesity #clinicaltrial"  
[X Link](https://x.com/Pharmashot/status/1978772085397729477) [@Pharmashot](/creator/x/Pharmashot) 2025-10-16T10:36Z 2279 followers, XX engagements


"MSD Unveils P-III (KEYNOTE-B96/ENGOT-ov65) Trial Findings on Keytruda for Platinum-Resistant Ovarian Cancer #merck #keynoteb96 #engotov65 #phase3 #keytruda #platinumresistantovariancancer #clinicaltrial #esmo2025 #rejoiceovarian01 #mk3475"  
[X Link](https://x.com/Pharmashot/status/1979133141043265572) [@Pharmashot](/creator/x/Pharmashot) 2025-10-17T10:31Z 2279 followers, XXX engagements


"Johnson & Johnson Reports the US FDAs sNDA Acceptance & Priority Review of Akeega to Treat Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) #jandj #akeega #metastaticcastrationsensitiveprostatecancer #niraparib #hrralterations #amplitude"  
[X Link](https://x.com/Pharmashot/status/1979149655838507302) [@Pharmashot](/creator/x/Pharmashot) 2025-10-17T11:37Z 2279 followers, XX engagements